Ambalal Sarabhai Enterprises Ltd vs Lactose India Ltd Stock Comparison
Ambalal Sarabhai Enterprises Ltd vs Lactose India Ltd Stock Comparison
Last Updated on: May 18, 2026
Key Highlights
The Latest Trading Price of Ambalal Sarabhai Enterprises Ltd is ₹ 31.26 as of 18 May 15:30
. The P/E Ratio of Ambalal Sarabhai Enterprises Ltd changed from 4.6 on March 2021 to 54.8 on March 2025 . This represents a CAGR of 64.14% over 5 yearsThe P/E Ratio of Lactose (India) Ltd changed from 0 on March 2021 to 0 on March 2025 . This represents a CAGR of 0.0% over 5 years The Market Cap of Ambalal Sarabhai Enterprises Ltd changed from ₹ 135.26 crore on March 2021 to ₹ 268.6 crore on March 2025 . This represents a CAGR of 14.71% over 5 yearsThe Market Cap of Lactose (India) Ltd changed from ₹ 0 crore on March 2021 to ₹ 0 crore on March 2025 . This represents a CAGR of 0.0% over 5 years The revenue of Ambalal Sarabhai Enterprises Ltd for the Dec '25 is ₹ 54.76 crore as compare to the Sep '25 revenue of ₹ 46.07 crore. This represent the growth of 18.86% The revenue of Lactose (India) Ltd for the Dec '25 is ₹ 0 crore as compare to the Sep '25 revenue of ₹ 0 crore. This represent the decline of 0% The ebitda of Ambalal Sarabhai Enterprises Ltd for the Dec '25 is ₹ 6.02 crore as compare to the Sep '25 ebitda of ₹ 1.98 crore. This represent the growth of 204.04% The ebitda of Lactose (India) Ltd for the Dec '25 is ₹ 0 crore as compare to the Sep '25 ebitda of ₹ 0 crore. This represent the decline of 0% The net profit of Ambalal Sarabhai Enterprises Ltd changed from ₹ 0.35 crore to ₹ 3.64 crore over 7 quarters. This represents a CAGR of 281.21%
The net profit of Lactose (India) Ltd changed from ₹ 0 crore to ₹ 0 crore over 7 quarters. This represents a CAGR of 0.0%
The Dividend Payout of Ambalal Sarabhai Enterprises Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of Lactose (India) Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 years .
About Ambalal Sarabhai Enterprises Ltd
Ambalal Sarabhai Enterprises Limited, incorporated on June 27, 1977, houses a range of companies across multi-dimensional businesses.
It is one of the oldest pharmaceutical health care companies in India, and through its group companies it manufactures and markets pharmaceutical, molecular diagnostics, and electronics products in India and internationally.
The Company produces a range of bulk drugs, pharmaceutical preparations and electronic instruments.
Pharmaceuticals segment is engaged in manufacture of drugs and formulations.
Electronics segment is engaged in manufacture of electronics instruments and services.
In 1994, the company entered into a technical collaboration with Biobras, Brazil, to manufacture highly purified insulin injections.
During the year 1997-98, the company formed a joint venture company, namely Sarabhai Piramal Pharmaceuticals Ltd with Piramal Enterprises Ltd for marketing of certain products under trademarks being used by the company.
About Lactose (India) Ltd
Lactose (India) Ltd was incorporated on March 1991 as a Public Limited Company in the Vadodara district of Gujarat.
The company is engaged in the manufacturing and trading of pharmaceutical products.
They offer edible and pharmaceutical grade lactose, which is used as an ingredient in pharmaceutical products, as well as in the dairy, food, confectionery, and beverage industries.
The company also manufactures dairy whitener, dairy calcium, whey powder, casein, caseinate, butter, and ghee.
Further, they engage in the contract manufacture of pharmaceutical products.
The company is having their manufacturing facilities located at Vadodara in Gujarat.
FAQs for the comparison of Ambalal Sarabhai Enterprises Ltd and Lactose (India) Ltd
Which company has a larger market capitalization, Ambalal Sarabhai Enterprises Ltd or Lactose (India) Ltd?
Market cap of Ambalal Sarabhai Enterprises Ltd is 239 Cr while Market cap of Lactose (India) Ltd is 142 Cr
What are the key factors driving the stock performance of Ambalal Sarabhai Enterprises Ltd and Lactose (India) Ltd?
The stock performance of Ambalal Sarabhai Enterprises Ltd and Lactose (India) Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.
What are the recent stock price for Ambalal Sarabhai Enterprises Ltd and Lactose (India) Ltd?
As of May 18, 2026, the Ambalal Sarabhai Enterprises Ltd stock price is INR ₹31.26. On the other hand, Lactose (India) Ltd stock price is INR ₹113.1.
How do dividend payouts of Ambalal Sarabhai Enterprises Ltd and Lactose (India) Ltd compare?
To compare the dividend payouts of Ambalal Sarabhai Enterprises Ltd and Lactose (India) Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.